Patient Advocate to Examine Engagement Strategies

Kevin J. Fowler

/kidneynews/9_10_11/37/graphic/37f1.jpg

“Effective Patient Engagement Strategies to Develop Future Therapies and Advance Patient Safety” is the title of the Celeste Castillo Lee Memorial Lectureship, scheduled for Friday, Nov. 3.

The speaker will be Kevin J. Fowler, a health care executive with more than 30 years of experience in pharmaceutical organizations.

Fowler spent more than 20 years at Pfizer, where his final position was senior director of public affairs. During a career involving a wide range of skills and experiences, he has demonstrated leadership in sales management, training, public affairs, global marketing, patient advocacy, and patient marketing.

His experience of having a preemptive kidney transplant in 2004 gave him a deep passion for patient advocacy and patient engagement. In 2014, he formed his own patient advocacy and patient engagement consulting business, The Voice of the Patient, Inc.

Fowler has brought this voice to several organizations as a volunteer, serving on the Kidney Health Initiative Patient Family Partnership Council, the advocacy committee of the National Kidney Foundation, the patient advisory group of the American Society of Transplantation, the board of directors of the American Association of Kidney Patients, and a patient advisory committee of the Kidney Research Institute.

He has designed digital patient customer relationship marketing programs and coordinated care strategies aimed at improving patient outcomes, creating brand loyalty, and reducing health care costs.

From 2007 to 2012, he served as the senior product manager for patient education and advocate relations at Astellas U.S., the U.S. affiliate of Tokyo-based Astellas Pharma. From 2013 to 2014, he served as a senior product manager for global marketing at AbbVie Inc., a biopharmaceutical company based in North Chicago, Ill.

October/November 2017 (Vol. 9, Number 10 & 11)